Gene editing ethics has emerged as a crucial topic in modern medicine, particularly with advancements in CRISPR technology that allow for precise alterations of our DNA.The potential to cure life-threatening conditions, such as sickle cell anemia, raises ethical dilemmas about who gets to decide which genes to alter and what implications those decisions might have on health equity.